Permanent Artificial Skin Market – Introduction

Permanent artificial skin is generally used in case of burn victims with superficial, deep, or partial wounds and chronic and acute wounds. Permanent artificial skin is a skin substitute employed for wound closure in order to replace the layer of the skin, especially at the burn site, permanently. Major advantages of artificial skin substitutes are increased wound healing, flexibility, and prevention of infection at the site of wound. Different types of permanent artificial skin are: epicel, alloderm, and integra. Epicel is also known as cultured epithelial auto graft. It is made from the patient’s own skin and cultured for 2–3 weeks before being used as a graft. Alloderm is employed to replace damaged soft tissue in case of deep wounds. It cannot be used for large surface areas. Integra is a permanent synthetic artificial skin substitute, which promotes growth of the cells and helps in formation of the red blood cells.

The global permanent artificial skin market is anticipated to be driven by increasing rate of incidence of burn injuries, growing rate of prevalence of chronic and acute wounds such as diabetic foot ulcers, rising R&D efforts for the development of new products, technological advancements such as sprays for treating burn injuries by using the patient’s own cells for rapid recovery, and increasing healthcare expenditure in developed as well as developing economies. On the other hand, high costs associated with artificial skin implant, stringent regulations regarding launch of new products, and low awareness in low-income economies are likely to be major restraints of the global permanent artificial skin market during the forecast period.

Identify the Key Factors that will drive your Company’s Growth. Request a Brochure of this Report here

Global Permanent Artificial Skin Market – Competition Landscape

Integra LifeSciences Corporation

Integra LifeSciences Corporation manufactures and develops wound reconstruction products such as skin substitutes. The company operates through two segments: Codman Specialty Surgical and Orthopedics & Tissue Technologies. Integra has a well-established product distribution network across the U.S., Europe, Asia Pacific, and other markets. The company was founded in 1989 at New Jersey, the U.S. On January 07, 2016, Integra LifeSciences Holdings Corporation announced to have received approval of the U.S. FDA for Integra Dermal Regeneration Template (IDRT) used in treating patients with diabetic foot ulcers.

Smith & Nephew plc.

Smith & Nephew was founded in 1856 in London, the U.K. The company’s product portfolio comprises skin substitutes. The company’s products are used for treating acute and chronic wounds caused by pressure ulcers and diabetic foot ulcers, post-operative wounds, and burns. The company’s artificial skin substitutes include PELNAC, a permanent skin substitute derived from the porcine tendon, which is used for repair and replacement of the damaged dermal layer.

Solsys Medical

The company’s product portfolio consists of wound care products used by healthcare professionals for treating chronic wounds. The company was established in 2017 in Virginia, the U.S. The company flagship product i.e. TheraSkin is made from allograft comprising growth factors and living cells used for closing and replacement of the damaged skin. In order to enhance product availability in the U.S., Solsys Medical entered into a strategic agreement with Premier Inc. in June 2017 to make TheraSkin available throughout 3,750 hospitals in the U.S.

Some of the other key players operating in the global permanent artificial skin market are Avita Medical, EUCARE PHARMACEUTICALS, and MiMedx.

Expanding Operations in Future? To get the Perfect launch ask for a Custom Report here

Global Permanent Artificial Skin Market – Dynamics

Increasing incidence of burn injuries to drive the demand for permanent artificial skin

Increasing incidence of burn injuries has led to increase in the demand for permanent artificial skin for efficient treatment of severe burns. Thus, manufacturers are constantly looking for opportunities for the development of new products through regular investments in research and development. According to the American Burn Association reports, approximately 40,000 patients were hospitalized for burn injuries in the U.S from 2017 to 2018 Similar studies have been reported by other major national organizations for burn injuries. For example, the CDC (Center for Diseases Control) has reported that approximately 10,000 individuals in the U.S. die every year due to infections caused after burn injuries. 

Increasing adoption of expansion strategies by major manufacturers to strengthen their geographical presence

Increasing demand for artificial skin substitutes has led to increase in adoption of expansion strategies by foreign manufactures to expand their geographical presence by introducing innovative products in newer geographies through strategic collaborations. For instance, on March 04, 2019, AVITA Medical collaborated with COSMOTEC, a subsidiary of M3 Group Company, for marketing and distribution of RECELL in Japan, which is used for the treatment of wounds caused by burns and other injuries. The launch of the product in Japan is anticipated to provide a lucrative opportunity for AVITA Medical, as there has been increase in the patient population suffering from chronic wounds and decubitus ulcers in Japan in recent times.

Stringent regulatory framework for new product approval to restrict market entry of new players

According to the FDA guidelines, skin substitute products are categorized as Class-III medical devices. They should protect and provide a stable biodegradable scaffold to promote healing of wounds. Therefore, failure in complying with the regulations set by different regulatory bodies, such as the FDA, can lead to failure to obtain a premarket approval for a new product. For instance, according to the FDA, use of biosynthetic products and animal-derived products is regulated under the 510K. Failure to adhere with this regulation can lead to delay in PMA (Pre-market Approval) and cause loss in revenues to manufacturers and restrict the market entry of new players. Thus, a stringent regulatory framework is anticipated to act as a restraint of the global permanent artificial skin market during the forecast period.

Global Permanent Artificial Skin Market – Segmentation

The global permanent artificial skin market can be segmented in terms of:

  • Product Type
  • Application
  • End-user
  • Region

Global Permanent Artificial Skin Market, by Product Type

Based on product type, the global permanent artificial skin market can be divided into:

  • Epidermal Skin
  • Dermal Skin

Global Permanent Artificial Skin Market, by End-user

In terms of end-user, the global permanent artificial skin market can be categorized into:

  • Hospitals
  • Burn Care Centers
  • Ambulatory Surgical Centers

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.  

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Permanent Artificial Skin Market

Pre Book